Giulia C. Kennedy - Chief Scientific & Med Officer at Veracyte, Inc.

Insider Transactions and Holdings

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	66K	$1.75M	$26.54	Dec 6, 2022	Direct
Stock Option (right to buy)	0		$26.55	Nov 11, 2022	Direct	Common Stock

Showing 1 to 2 of 2 entries

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.